Patent · US Active

Use of a flavanol glycoside for suppressing activation of stellate cells

US9260466B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

Hong Kong Baptist University · CN

Inventors

Zhaoxiang BIAN · Sha Tin, CN
Siu Wai Tsang · Sha Tin, CN
Hongjie Zhang · Sha Tin, CN
Yegao Chen · Kowloon, CN
Aiping Lu · Kowloon, CN
Albert Sun-Chi Chan · Kowloon, CN
Hongxi XU · Kowloon, CN
Shilin Chen · Conroe, US
Dajian YANG · Sha Tin, CN

Key dates

Filing date	May 22, 2013
Grant date	Feb 16, 2016
Priority date	—
Expiry date	Jul 22, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2236/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for suppressing activation of pancreatic stellate cells of a subject includes administering a composition comprising a therapeutically effective amount of Eruberin A. A method of preventing, alleviating or treating pancreatic tumors or pancreatic tumors related diseases includes administering a composition comprising a therapeutically effective amount of Eruberin A. The Eruberin A may be extracted from Pronephrium penangianum.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.